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Clinical background
Lung cancer (LC) is the leading cause of cancer-related
death among people living with HIV (PLWH) [1]. In the
general population, adenocarcinoma is more common in
women with LC, while squamous cell carcinoma (SqCC)
is more common in men. Survival after lung cancer is
worse among PLWHA. We explore potential gender-
related difference in lung cancer in HIV+ and HIV-
patients.
Methods
A retrospective review of the hospital cancer registry
from 2000-2010 was performed. HIV status of identified
lung cancer patients was assessed. Demographics, stage
of cancer, and outcome were recorded for HIV+ and
HIV- patients. Data were analyzed using SAS 9.1.
Results
Over the 10-year period, 1250 lung cancer cases were
identified (75HIV+, 205 HIV-, and 970 unknown HIV sta-
tus. There were 20 women (W+) and 55 men (M+) with
HIV, and 85 women (W-) and 120 men (M-) who are
HIV-. There were significantly more men tested for HIV
at cancer diagnosis than women (p=0.0001). The distribu-
tion of lung cancer type is similar among the HIV+ and
HIV-. Median age at cancer diagnosis is not significantly
different with W+(50 years old), W-(55) , M+(55) and M-
(58 ). Presentation at stage IIIB or IV occurred in 69%W+,
67% W, 68%M+ and 73%M-. There is no difference of
median CD4 (W+=233, M+=159, p=0.1) or HAART use
at cancer diagnosis among M+( 53%) or W+( 63%) ,
p=0.4. The median survival time for W+(386 days),
M+(192 days ), W-(475 day) and M-(247 days) . There is
trend for longer survival for W+ versus M+ (log rank
p=0.07), as well as W- versus M- (log rank p=0.06), but no
difference for W+ vsW- (LR p=0.7) or M+ vs M- (LR
p=0.8).
Conclusion
The experience in our hospital reveals that in the HAART
era, there does not seem to be a difference in lung cancer
presentation among HIV+ or HIV- patients, and that
there is a trend for better survival among women com-
pared to men.whether HIV+ or HIV-. Further studies are
needed to explain this gender difference.
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